Vaccine Supply Shortages in Lahore Linked to Regulatory Price Delays
What happened
Federal Health Minister Mustafa Kamal stated that flu vaccines remain available in the market in Pakistan, though he noted that specific multinational brands are unavailable. This statement occurred as store owners in Lahore reported that vaccines were largely unavailable, with only a Chinese-manufactured vaccine reaching the market in limited quantities. The unavailability of certain brands, including Abbot, is attributed to the federal cabinet not yet approving their requested prices.
From geo.tv
Why it matters
The inability to import vaccines from two multinational companies due to pending price approval has created supply constraints in Lahore. This limited supply has reportedly caused the price of a vaccine to increase from Rs1,200 to Rs1,640.
From geo.tv
Who's involved
- Mustafa KamalFederal Health Minister who discussed vaccine availability
- PakistanThe sovereign state where the supply issues are occurring
- LahoreThe location in Pakistan where vaccine shortages were reported
- AbbotOne of the multinational vaccine brands whose import is delayed
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Abbot vaccine supply may be blocked by pricing approval delaysAbbot's vaccine availability may be hampered by federal pricing approval delaysPossible
- Vaccine shortages and pricing delays may strain Pakistan's health marketRegulatory delays and supply issues may disrupt Pakistan's vaccine market.Possible
Keep exploring
The entities involved
-
Lahore
capital of the Punjab province, Pakistan
-
Mustafa Kamal
Bangladeshi politician and cricket official